Table 9 Multivariate analysis for breast-cancer survival
Parameters | Disease-free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value | |
T stage | 0.003 | 0.008 | ||||
T1 versus T2-3 | 2.535 | 1.376 − 4.670 | 2.218 | 1.229 − 4.001 | ||
N stage | 0.002 | 0.026 | ||||
N0 versus N1-3 | 2.257 | 1.335 − 3.816 | 1.831 | 1.076 − 3.115 | ||
Histologic grade | 0.045 | 0.372 | ||||
I/II versus III | 1.685 | 1.013 − 2.804 | 1.276 | 0.748 − 2.176 | ||
Nuclear HIF-1α | 0.599 | 0.486 | ||||
Negative versus Positive | 0.682 | 0.163 − 2.846 | 0.599 | 0.142 − 2.528 | ||
Tumor SDHA | 0.290 | 0.002 | ||||
Negative/Low versus High | 1.570 | 0.681 − 3.620 | 4.157 | 1.657 − 10.432 | ||
Stromal SDHA | 0.727 | 0.747 | ||||
Negative versus Positive | 1.254 | 0.352 − 4.468 | 0.807 | 0.218 − 2.978 | ||
Tumor SDHB | 0.096 | 0.012 | ||||
Negative/Low versus High | 0.498 | 0.219 − 1.131 | 3.223 | 1.295 − 8.025 | ||
Stromal SDHB | 0.712 | 0.965 | ||||
Negative versus Positive | 0.802 | 0.248 − 2.590 | 0.976 | 0.327 − 2.908 | ||